Avanafil
| パラメータ | 仕様 |
|---|---|
| 製品名 | Avanafil |
| CAS番号 | 330784-47-9 |
| 分子式 | C23H26ClN7O3 |
| 分子量 | 483.95 g/mol |
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 分析(HPLC) | ≥99.0% |
| 溶解度 | Soluble in DMSO, slightly soluble in ethanol, practically insoluble in water |
| パッケージ | 25 kg net weight in fiber drums with double polyethylene liners |
お困りですか? 弊社チームまでお問い合わせください

同義語: TA-1790, 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide, Avanafilum, Stendra, Spedra, TA 1790
Avanafil is a highly selective phosphodiesterase type 5 (PDE5) inhibitor developed for the treatment of erectile dysfunction. It is a synthetic small-molecule API manufactured under cGMP conditions, available as a white to off-white crystalline powder with an assay of ≥99.0% by HPLC.
Known commercially as Stendra and Spedra, Avanafil is distinguished by its rapid onset of action and high selectivity for PDE5 over other phosphodiesterase isoenzymes, which translates into a favorable side-effect profile. As a bulk API, it serves formulators developing oral solid dosage forms, including immediate-release tablets and orally disintegrating formulations.
| Test Item | 仕様 |
|---|---|
| 識別 | IR and HPLC retention time conform to reference standard |
| 乾燥減量 | ≤0.5% |
| 焼失残渣 | ≤0.11 TP3T |
| 重金属 | ≤20 ppm |
| Organic Impurities | Any individual impurity ≤0.5%; total impurities ≤1.0% |
| Microbial Limits | Total aerobic count ≤1000 CFU/g; yeast and mold ≤100 CFU/g; absence of E. coli and Salmonella |
Our standard MOQ is 1 kg for stock items. For custom packaging or larger quantities, the MOQ is 25 kg. We can accommodate smaller quantities for research and development upon request.
For stock items, the lead time is 3-5 business days from order confirmation. We ship globally via express couriers and air freight.
Yes, a COA is provided with every shipment. Samples for analytical evaluation are available upon request; sample dispatch typically takes 1-2 days after approval.
send us your specification for a quotation.